Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Osteoporosis 5Breast Neoplasms 5Colorectal Neoplasms 4Vitamin D Deficiency 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Neoplasms 3Thyroid Neoplasms 2Lymphoma 2Leukemia 2Colonic Neoplasms 2Adenomatous Polyps 2Adenoma 2Thyroiditis 1Prostatic Neoplasms 1Polyps 1Polycystic Ovary Syndrome 1Pain 1Ovarian Neoplasms 1Osteosarcoma 1Obesity 1Myelodysplastic Syndromes 1Lymphoma, Non-Hodgkin 1Hypocalcemia 1Hyperthyroidism 1Goiter 1Colonic Polyps 1Bone Diseases, Metabolic 1Arthralgia 1Aflatoxin Poisoning 1

Interventions

Zoledronic Acid 6Risedronic Acid 5Calcium 4Vitamin D 3Denosumab 3Letrozole 2Toremifene 1Nutrition Assessment 1Kyphoplasty 1Ibandronic Acid 1Health Promotion 1Geritol 1Exercise Movement Techniques 1Exercise 1Cholecalciferol 1Calcium Carbonate 1Aromatase Inhibitors 1Anastrozole 1ARQ 197 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Bone Diseases, Metabolic × Calcium Carbonate × Clear all
NCT00352846 2013-07-02

Effect of Zoledronic Acid on Chemotherapy Induced Bone Loss

M.D. Anderson Cancer Center

Phase 3 Completed
135 enrolled 4 charts
Lymphoid

Bone Diseases, Metabolic, Lymphoma, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon âš¡